NeuroSense Therapeutics Ltd
NRSN
Market Cap$23.56M
Close$
$0.18
83% downside
Current Fair Value
83% downsideOvervalued by 83% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $23.56 Million |
|---|---|
| Enterprise Value | $20.25 Million |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-0.74 |
| Beta | 1.56 |
| Outstanding Shares | 15,405,253 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -2.3 |
|---|---|
| PEG | 0.62 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -1.77 |
| Enterprise Value to Net Income | -2 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0.03 |
Revenue Sources
No data
Insider Trades
ESG Score
No data